medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2009, Number 4

<< Back Next >>

An Med Asoc Med Hosp ABC 2009; 54 (4)

Implications of obesity in the response to lymphedema treatment secondary to radical modified mastectomy with axillary dissection

Aloi-Timeus SI, Gerson R, Montañez RH, Olivares MH

Language: Spanish
References: 13
Page: 197-200
PDF size: 41.53 Kb.


ABSTRACT

This prospective, longitudinal and comparative study was undertaken at the ABC Medical Center in Mexico City, between September 2004 and August 2006, divided into two comparative groups of 30 patients each. A control group with less than a 30% body mass index (BMI) and a problem group with a BMI equal to or greater than 30%. All patients were assessed, initially with circumferential measurement in centimeters of hand, wrist, forearm, elbow, arm and axilla, as well as complex decongestant physical therapy (CDT). Five sessions per week, in a three week period, inclusion criteria considered patients with no active tumor, a modified radical mastectomy and grade I and II lymphedema. Measurements were compared taking the basal ones with the three week treatment with CDT, and found that the control group with a BMI of lower than a 30%, had an improved response as of the second week of treatment in all the circumferential measurements except for the axilla. Nevertheless, in the group with a BMI greater than 30% there was no significant improvement with CDT until the third week of treatment and only for the wrist and axilla, which demonstrates inefficient treatment of secondary lymphedema regardless of an early of CDT management.


REFERENCES

  1. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003; 115 (suppl 8A): 37S-41S.

  2. Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance and cardiovascular disease. Recent Prog Res 2004; 59: 207-223.

  3. Irigaray P, Nweby JA, Lacomme S, Belpomme D. Overweight/obesity and cancer genesis: More than a biological link. Biomed Pharmacother 2007 Nov 1.

  4. Ceschi M, Gutzwiller F, Moch H, Eichholzer M, Probst-Hensch NM. Epidemiology and pathophysiology of obesity as cause of cancer. Swiss Med Wkly 2007; 137 (3-4): 50-56.

  5. Mukherjee S, Koner BC, Ray S, Ray A. Environmental contaminants and pathogenesis of breast cancer. Indian J Exp Biol 2006; 44 (8): 597-617.

  6. McTiernan A. Obesity and cancer: The risk, science, and potential management strategies. Oncology (Williston Park) 2005; 19 (7): 871-886.

  7. Wisse BE, Kim F, Schwartz MW. Physiology. An integrative view of obesity. Science 2007; 318 (5852): 928-929.

  8. Bertelli G, Venturini M, Forno G. An analysis of prognostic factors in response to conservative treatment of postmastectomy lymphoedema. Surg Gynecol Obstet 1992; 175: 455.

  9. Yosipovitch G, DeVore A, Dawn A. Obesity and the skin: skin physiology and skin manifestations of obesity. J Am Acad Dematol 2007; 56 (6): 901-920.

  10. van der Veen P, De Voogdt N, Lievens P, Duquet W, Lamote J, Sacre R. Lymphedema development following breast cancer surgery with full axillary resection. Lymphology 2004; 37(4): 206-208.

  11. Kopansky Z, Wojewoda T, Wojewoda A, Schlegel-Zawadazka M, Wozniacka R, Suder A, Kosciuk T. Influence of some anthropometric parameters on the risk of development of distal complications after mastectomy carried out because of breast carcinoma. Am J Hum Biol 2003; 15 (3): 433-439.

  12. Banerjee D, Williams EV, Ilott J, Monypenny IJ, Webster DJ. Obesity predisposes to increased drainage following axillary node clearance: a prospective audit. Ann R Coll Surg Engl 2001; 83 (4): 268-271.

  13. Shaw C, Mortimer P, Judd PA. Randomized controlled trial comparing a low fat diet with a weight reduction diet in breast cancer-related lymphedema. Cancer 2007; 109 (10): 1949-1956.




2020     |     www.medigraphic.com